Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies
Titel:
Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies
Auteur:
Kummar, Shivaani Gutierrez, Martin E. Gardner, Erin R. Chen, Xiaohong Figg, William D. Zajac-Kaye, Maria Chen, Min Steinberg, Seth M. Muir, Christine A. Yancey, Mary Ann Horneffer, Yvonne R. Juwara, Lamin Melillo, Giovanni Ivy, S. Percy Merino, Maria Neckers, Len Steeg, Patricia S. Conley, Barbara A. Giaccone, Giuseppe Doroshow, James H. Murgo, Anthony J.